Medical device for analyte monitoring and drug delivery
CA 2852974 C · Owner: Theranos Ip Company, Llc · Inventors: Roy, Shaunak; Howard, John; Wang, Chengwang
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to an ingestible implantable or wearable medical device comprising a microarray having a bioactive agent capable of interacting with a disease marker biological analyte; a reservoir which comprises at least one therapeutic agent; and a microchip comprising a microarray scanning device capable of obtaining physical parameter data of an interaction between the disease marker biological analyte with the bioactive agent; a biometric recognition device capable of comparing the physical parameter data with an analyte interaction profile; and an interface device capable of facilitating communications between the microarray scanning device biometric recognition device and a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 10, 2004 and granted June 27, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 10, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 10, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.